John Bergsagel

446 total citations
20 papers, 283 citations indexed

About

John Bergsagel is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, John Bergsagel has authored 20 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in John Bergsagel's work include Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Acute Myeloid Leukemia Research (3 papers). John Bergsagel is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Acute Myeloid Leukemia Research (3 papers). John Bergsagel collaborates with scholars based in United States, Canada and Germany. John Bergsagel's co-authors include Mariateresa Giuliano, Michele Carbone, Robert L. Garcea, Mark C. Gebhardt, Antonio Domenico Procopio, Franca Pompetti, Harvey I. Pass, Marc F. Hansen, Paola Rizzo and Piero Picci and has published in prestigious journals such as Cancer, Journal of Cellular Physiology and BMC Cancer.

In The Last Decade

John Bergsagel

15 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Bergsagel United States 7 121 69 53 47 46 20 283
S Kojima Japan 7 140 1.2× 144 2.1× 33 0.6× 18 0.4× 12 0.3× 14 341
Anthony Sabulski United States 8 124 1.0× 56 0.8× 29 0.5× 18 0.4× 30 0.7× 37 272
M Kawakami Japan 7 88 0.7× 145 2.1× 37 0.7× 268 5.7× 15 0.3× 14 423
Ghadir Sasa United States 11 109 0.9× 108 1.6× 16 0.3× 101 2.1× 8 0.2× 38 363
Kirsten M Boughan United States 7 146 1.2× 93 1.3× 24 0.5× 54 1.1× 16 0.3× 35 263
Daphna Hutt Israel 10 147 1.2× 67 1.0× 14 0.3× 42 0.9× 25 0.5× 20 282
Sophia Bennett United Kingdom 9 97 0.8× 15 0.2× 12 0.2× 42 0.9× 20 0.4× 9 237
Joaquín Sánchez‐García Spain 10 77 0.6× 169 2.4× 65 1.2× 48 1.0× 10 0.2× 26 306
Ben Carpenter United Kingdom 11 160 1.3× 77 1.1× 22 0.4× 30 0.6× 7 0.2× 28 320
S Masuo Japan 9 132 1.1× 197 2.9× 37 0.7× 10 0.2× 6 0.1× 11 251

Countries citing papers authored by John Bergsagel

Since Specialization
Citations

This map shows the geographic impact of John Bergsagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bergsagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bergsagel more than expected).

Fields of papers citing papers by John Bergsagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Bergsagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bergsagel. The network helps show where John Bergsagel may publish in the future.

Co-authorship network of co-authors of John Bergsagel

This figure shows the co-authorship network connecting the top 25 collaborators of John Bergsagel. A scholar is included among the top collaborators of John Bergsagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Bergsagel. John Bergsagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Stephanie M., Himalee S. Sabnis, Karen E. Effinger, et al.. (2021). Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias. BMC Cancer. 21(1). 474–474. 3 indexed citations
2.
Weinzierl, Elizabeth P., Debra Saxe, John Bergsagel, et al.. (2020). Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1‐PDGFRA‐Associated Myeloid Neoplasm With Eosinophilia. HemaSphere. 4(6). e486–e486. 4 indexed citations
3.
Athale, Uma H., Nobuko Hijiya, Briana C. Patterson, et al.. (2019). Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatric Blood & Cancer. 66(9). e27827–e27827. 46 indexed citations
4.
Raikar, Sunil S., John D. Scarborough, Himalee S. Sabnis, et al.. (2016). Early T‐Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia. Pediatric Blood & Cancer. 63(9). 1667–1670. 3 indexed citations
5.
Bergsagel, John, David Hiley, & Thomas Riis. (2015). Of chronicles and kings : national saints and the emergence of nation states in the High Middle Ages. Medical Entomology and Zoology. 1 indexed citations
6.
Zerra, Patricia E., John Bergsagel, Frank G. Keller, Glen Lew, & Melinda Pauly. (2015). Maintenance Treatment With Low‐Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine‐Induced Pancreatitis. Pediatric Blood & Cancer. 63(4). 712–715. 17 indexed citations
7.
Rassi, Fuad El, John Bergsagel, Martha Arellano, et al.. (2014). Predicting early blast transformation in chronic‐phase chronic myeloid leukemia: Is immunophenotyping the missing link?. Cancer. 121(6). 872–875. 16 indexed citations
8.
Nickel, Robert Sheppard, Frank G. Keller, John Bergsagel, et al.. (2013). Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma. Pediatric Blood & Cancer. 61(5). 810–814. 13 indexed citations
9.
Howell, Della L., John Bergsagel, Roland Chu, & Lillian R. Meacham. (2004). Suppression of Hodgkin???s Disease in a Patient With Cushing???s Syndrome. Journal of Pediatric Hematology/Oncology. 26(5). 301–303. 2 indexed citations
10.
Bergsagel, John. (2002). Siboni, Erik Anthon Valdemar (opera). Oxford Music Online. 1 indexed citations
11.
Bergsagel, John. (2001). Christian IV, King of Denmark and Norway. Oxford Music Online.
12.
Carbone, Michele, Paola Rizzo, Antonio Domenico Procopio, et al.. (1996). SV40-like sequences in human bone tumors.. PubMed. 13(3). 527–35. 143 indexed citations
13.
Bergsagel, John, et al.. (1994). Ole Bull: Norway's Romantic Musician and Cosmopolitan Patriot. Notes. 51(2). 601–601. 3 indexed citations
14.
Bergsagel, John. (1990). The Transmission of Notre Dame Organa in SOme Newly-Discovered "Magnus liber organi" Fragments in Copenhagen. Dialnet (Universidad de la Rioja). 629–636. 1 indexed citations
15.
Shales, Michael, John Bergsagel, & C. James Ingles. (1980). Defective RNA polymerase II in the G1 specific temperature sensitive hamster cell mutant TsAF8. Journal of Cellular Physiology. 105(3). 527–532. 19 indexed citations
16.
Bergsagel, John. (1972). Cordier's Circular Canon. The Musical Times. 113(1558). 1175–1175.
17.
Bergsagel, John & Patricia Howard. (1970). The Operas of Benjamin Britten. An Introduction. Notes. 27(1). 54–54. 1 indexed citations
18.
Bergsagel, John, et al.. (1970). Henry Purcell 1659-1695. Notes. 26(3). 513–513. 2 indexed citations
19.
Bergsagel, John, et al.. (1964). Early Tudor Masses, I. (Early English Church Music, 1.). Notes. 21(3). 442–442. 1 indexed citations
20.
Bergsagel, John. (1963). THE DATE AND PROVENANCE OF THE FORREST-HEYTHER COLLECTION OF TUDOR MASSES. Music and Letters. 44(3). 240–248. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026